文献速递妇科

高龄加速而多产延迟小鼠高级别浆液性癌模型中的肿瘤发生

Aging accelerates while multiparity delays tumorigenesis in mouse models of high-grade serous carcinoma.
PubMed 文献 · Gynecol Oncol · 2022-04-09

该研究利用他莫昔芬诱导BPRN小鼠输卵管上皮肿瘤 suppressor 基因失活的高级别浆液性癌(HGSC)模型,发现9月龄小鼠肿瘤诱导后生存期显著短于6-8周龄小鼠(中位46.5周 vs 61.5周,log-rank P=0.0006),多产与未产小鼠在BPRN模型中癌症表型无显著差异,但在BPRNfl/+模型中未产小鼠肿瘤更晚期(P=0.01)。

要点

  • 9月龄BPRN小鼠肿瘤诱导后生存期显著短于6-8周龄小鼠(中位46.5周 vs 61.5周,P=0.0006)。
  • 多产与未产BPRN小鼠之间癌症表型无显著差异。
  • BPRNfl/+模型中未产小鼠肿瘤较多产小鼠更晚期(P=0.01)。

核心结论

  • 在高龄小鼠中,肿瘤诱导后生存期显著缩短,多产在特定遗传背景下延迟HGSC的发生和/或进展。

研究设计与样本

  • 使用他莫昔芬诱导BPRN小鼠输卵管上皮中Brca1、Trp53、Rb1和Nf1肿瘤抑制基因体细胞失活的HGSC小鼠模型。
  • BPRN小鼠在特定年龄和产次状态下接受他莫昔芬诱导肿瘤。
  • 另使用携带一个野生型Nf1等位的改良肿瘤模型(BPRNfl/+)。

主要发现

  • 9月龄BPRN小鼠肿瘤诱导后生存期显著短于6-8周龄小鼠(中位46.5周 vs 61.5周,log-rank检验P=0.0006)。
  • 多产与未产BPRN小鼠之间未观察到癌症表型的显著差异。
  • 在BPRNfl/+模型中,未产小鼠较多产小鼠肿瘤更晚期(Mantel-Haenszel关联卡方检验P=0.01)。

临床怎么用

  • 作者认为该小鼠模型可用于获取已知因素如何发挥保护作用的机制见解,并测试HGSC预防的新方法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The "incessant ovulation" hypothesis links increased risk for tubo-ovarian high-grade serous carcinoma (HGSC) due to more ovulations and reduced risk conferred by pre-menopausal exposures like oral contraceptive use, multiparity, and breastfeeding. However, most women diagnosed with HGSC are postmenopausal, implying age is a major risk factor for HGSC. Our mouse model for HGSC, based on tamoxifen (TAM)-induced somatic inactivation of the Brca1, Trp53, Rb1, and Nf1 (BPRN) tumor suppressor genes in oviductal epithelium, recapitulates key genetic, histopathologic, and biological features of human HGSCs. We aimed to credential the model for future efforts to define biological and risk modification factors in HGSC pathogenesis. METHODS: BPRN mice were treated with TAM to induce tumors at defined ages and parity status. RESULTS: BPRN mice aged 9-months prior to tumor induction had markedly shorter survival than 6-8 week old mice induced to form tumors (median 46.5 weeks versus 61.5 weeks, log-rank test P = 0.0006). No significant differences in cancer phenotypes were observed between multiparous versus nulliparous BPRN mice. However, using a modified tumor model with one wild-type Nf1 allele (BPRNfl/+), nulliparous mice had more advanced tumors than multiparous mice (Mantel-Haenszel Chi-square test of association, P = 0.01). CONCLUSIONS: Our findings show aging is associated with significantly shortened survival post tumor induction in the BRPN model and multiparity delays development and/or progression of HGSC in certain genetic contexts. The findings support relevance of our mouse model to gain mechanistic insights into how known factors exert their protective effects and to test novel approaches for HGSC prevention.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Hou X, Zhai Y, Hu K, et al. Aging accelerates while multiparity delays tumorigenesis in mouse models of high-grade serous carcinoma. Gynecol Oncol. 2022. PMID: 35414426. doi:10.1016/j.ygyno.2022.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。